Azilsartan medoxomil (trade name Edarb) is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. It is indicated for the treatment of hypertension to lower blood pressure which reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Azilsartan medoxomil may be used either alone or in combination with other antihypertensive agents such as chlorthalidone (CLD). As an ARB, azilsartan medoxomil selectively inhibits angiotensin II from binding to the angiotensin II type-1 receptor (AT1). This receptor inhibition provides the antihypertensive activity of azilsartan medoxomil because it blocks the pressor effects of angiotensin II. Azilsartan medoxomil is a prodrug of azilsartan. It is hydrolyzed to the active moiety, azilsartan, in the gastrointestinal (GI) tract during the absorption phase. This report contains market size and forecasts of Azilsartan Medoxomil API in global, including the following market information: Global Azilsartan Medoxomil API Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Azilsartan Medoxomil API Market Sales, 2017-2022, 2023-2028, (Kg) Global top five Azilsartan Medoxomil API companies in 2021 (%) The global Azilsartan Medoxomil API market was valued at 15 million in 2021 and is projected to reach US$ 53 million by 2028, at a CAGR of 19.1% during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. 0.99 Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Azilsartan Medoxomil API include Takeda, Lupin, Acura Labs, Metrochem API, Jubilant Pharma, Zhejiang Hongyuan, Honour Lab, HEC Pharm and Enomark, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Azilsartan Medoxomil API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Azilsartan Medoxomil API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg) Global Azilsartan Medoxomil API Market Segment Percentages, by Purity, 2021 (%) 0.99 Others Global Azilsartan Medoxomil API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg) Global Azilsartan Medoxomil API Market Segment Percentages, by Application, 2021 (%) 20 mg Tablets 40 mg Tablets 80 mg Tablets Global Azilsartan Medoxomil API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg) Global Azilsartan Medoxomil API Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Azilsartan Medoxomil API revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Azilsartan Medoxomil API revenues share in global market, 2021 (%) Key companies Azilsartan Medoxomil API sales in global market, 2017-2022 (Estimated), (Kg) Key companies Azilsartan Medoxomil API sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Takeda Lupin Acura Labs Metrochem API Jubilant Pharma Zhejiang Hongyuan Honour Lab HEC Pharm Enomark CTX Life Sciences Zhejiang Tianyu Zhuhai Rundu Valiant Co
1 Introduction to Research & Analysis Reports 1.1 Azilsartan Medoxomil API Market Definition 1.2 Market Segments 1.2.1 Market by Purity 1.2.2 Market by Application 1.3 Global Azilsartan Medoxomil API Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
